Correlation Between Kiora Pharmaceuticals and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Editas Medicine, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Editas Medicine.
Diversification Opportunities for Kiora Pharmaceuticals and Editas Medicine
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kiora and Editas is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Editas Medicine go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Editas Medicine
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 1.39 times more return on investment than Editas Medicine. However, Kiora Pharmaceuticals is 1.39 times more volatile than Editas Medicine. It trades about 0.01 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.11 per unit of risk. If you would invest 465.00 in Kiora Pharmaceuticals on August 26, 2024 and sell it today you would lose (128.00) from holding Kiora Pharmaceuticals or give up 27.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Editas Medicine
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Editas Medicine |
Kiora Pharmaceuticals and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Editas Medicine
The main advantage of trading using opposite Kiora Pharmaceuticals and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |